{
    "clinical_study": {
        "@rank": "16589", 
        "arm_group": [
            {
                "arm_group_label": "ONS group", 
                "arm_group_type": "Experimental", 
                "description": "oral administration of Encover 2 package for day starting at the time of discharge (200ml/package x 2, total 400Kcal/day) total 87 patients"
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "no intervention total 87 patients"
            }
        ], 
        "brief_summary": {
            "textblock": "Patients who underwent major gastrointestinal surgery is potentially at risk of malnutrition\n      due to reduced oral intake, increased nutritional need, reduced gastrointestinal absorption\n      function, and/or metabolic changes after surgery. The postoperative malnutrition is\n      associated with low quality of life and seems to be related long-term nutritional status.\n      This study is a multicenter, open-labeled prospective randomized clinical trial to examine\n      the effect of postoperative oral nutritional supplements (ONS) after major gastrointestinal\n      surgery by comparing the change of body weight and other nutritional parameters between the\n      experiment group that is supplied with ONS and the control group without ONS."
        }, 
        "brief_title": "Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery", 
        "condition": [
            "Gastric Cancer", 
            "Colon Cancer", 
            "Pancreatic Cancer", 
            "Duodenal Cancer", 
            "Biliary Cancer", 
            "Peptic Ulcer", 
            "Inflammatory Bowel Diseases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Colonic Neoplasms", 
                "Duodenal Neoplasms", 
                "Inflammatory Bowel Diseases", 
                "Intestinal Diseases", 
                "Stomach Neoplasms", 
                "Pancreatic Neoplasms", 
                "Peptic Ulcer", 
                "Ulcer", 
                "Biliary Tract Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female who are 20 or more years old and not more than 80 years old\n\n          -  Discharge from a hospital is planned within 2 weeks after major gastrointestinal\n             surgery (except when ileostomy is performed)\n\n          -  oral intake is possible at the time of discharge\n\n          -  no preoperative chemotherapy or preoperative radiotherapy\n\n          -  voluntarily agreed with the informed consent of this clinical trial\n\n        Exclusion Criteria:\n\n          -  Intravenous or other specific nutritional treatment is needed\n\n          -  BMI >25 and postoperative weight loss is not > 5% of preoperative body weight at the\n             time of discharge\n\n          -  Allergy to milk, whey, bean, salmon, or the investigational product\n\n          -  Residual of cancer in the abdominal cavity postoperatively if it is cancer case\n\n          -  Presence of synchronous other cancers that needs treatment.\n\n          -  When investigator judged that the patient is not eligible to the trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "174", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01838109", 
            "org_study_id": "KSSMN-01"
        }, 
        "intervention": {
            "arm_group_label": "ONS group", 
            "intervention_name": "oral nutritional supplement", 
            "intervention_type": "Dietary Supplement", 
            "other_name": "Encover"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 4, 2013", 
        "location": {
            "contact": {
                "email": "appe98@snu.ac.kr", 
                "last_name": "Hyuk-Joon Lee, MD, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul National University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Multicenter, Prospective Randomized Controlled Trial Evaluating Postoperative Oral Nutritional Supplementation for the Patients Who Received Major Gastrointestinal Surgery", 
        "other_outcome": [
            {
                "measure": "Anthropometric measure (Triceps Skinfold Thickness and Mid Arm Muscle Circumference), optional", 
                "safety_issue": "No", 
                "time_frame": "pre-operatively, and 2,4,8 weeks after discharge"
            }, 
            {
                "measure": "ONS related gastrointestinal adverse event", 
                "safety_issue": "Yes", 
                "time_frame": "upto 8weeks after discharge"
            }
        ], 
        "overall_contact": {
            "email": "appe98@snu.ac.kr", 
            "last_name": "Hyuk-Joon Lee, MD. PhD"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Hyuk-Joon Lee, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Body weight decrease rate  8weeks after discharge compared with preoperative body weight", 
            "safety_issue": "No", 
            "time_frame": "8weeks after discharge"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01838109"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Changes in body weight before and after surgery", 
                "safety_issue": "No", 
                "time_frame": "preoperatively, at the time of discharge, and 2,4, 8 weeks after discharge"
            }, 
            {
                "measure": "Change of body mass index before and after surgery", 
                "safety_issue": "No", 
                "time_frame": "preoperatively, at the time of discharge after surgery, and 8 weeks after discharge"
            }, 
            {
                "measure": "changes in PG-SGA score and grade", 
                "safety_issue": "No", 
                "time_frame": "preoperatively, and 2,4,8 weeks after discharge"
            }, 
            {
                "measure": "serum hemoglobin", 
                "safety_issue": "No", 
                "time_frame": "preoperatively, at the time of discharge, 2,4,8 weeks after discharge"
            }, 
            {
                "measure": "serum total lymphocyte count", 
                "safety_issue": "No", 
                "time_frame": "preoperatively, at the time of discharge, 2,4,8 weeks after discharge"
            }, 
            {
                "measure": "serum total cholesterol", 
                "safety_issue": "No", 
                "time_frame": "preoperatively, at the time of discharge, 2,4,8 weeks after discharge"
            }, 
            {
                "measure": "serum total protein", 
                "safety_issue": "No", 
                "time_frame": "preoperatively, at the time of discharge, 2,4,8 weeks after discharge"
            }, 
            {
                "measure": "serum albumin", 
                "safety_issue": "No", 
                "time_frame": "preoperatively, at the time of discharge, 2,4,8 weeks after discharge"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "JW Pharmaceutical", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}